Fund Details
Overview
Investment portfolio
15rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
HighLife | Sep 2026Participated | $92 MOther Equity | |
NinaMED | May 2026Led | $14 MOther Equity | |
ErVimmune | Jan 2026Led | $20 MSeries A | |
KAHR medical | Jan 2026Participated | $32 MOther Equity | |
Lattice Medical | Oct 2025Participated | $50 MSeries B | |
Vaxxas | Aug 2025Led | $58 MSeries D | |
Azalea Vision | Apr 2025Participated | $11 MSeries A | |
RheumaGen | Jan 2025Led | $15 MSeries A | |
Doron Therapeutics | Nov 2024Led | $11 MSeries A | |
Prota Therapeutics | Jan 2024Led | $21 MOther Equity | |
Stalicla | Jan 2024Led | $17 MSeries B | |
Spexis | Aug 2023Led | $3 MDebt | |
HighLife | Sep 2026Participated | $92 MOther Equity | |
NinaMED | May 2026Led | $14 MOther Equity | |
ErVimmune | Jan 2026Led | $20 MSeries A | |
KAHR medical | Jan 2026Participated | $32 MOther Equity | |
Lattice Medical | Oct 2025Participated | $50 MSeries B | |
Vaxxas | Aug 2025Led | $58 MSeries D | |
Azalea Vision | Apr 2025Participated | $11 MSeries A | |
RheumaGen | Jan 2025Led | $15 MSeries A | |
Doron Therapeutics | Nov 2024Led | $11 MSeries A | |
Prota Therapeutics | Jan 2024Led | $21 MOther Equity | |
Stalicla | Jan 2024Led | $17 MSeries B | |
Spexis | Aug 2023Led | $3 MDebt |
15 Items
15
Items
...
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 3 | 3 |
| Series B | 1 | 2 |
| Series C+ | 1 | 0 |
| Other Equity | 2 | 2 |
| Debt | 1 | 0 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jul '21 | 1 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 1 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 1 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 1 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 2 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 1 |
| Dec '24 | 0 |
| Jan '25 | 1 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 1 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 1 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 2 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 1 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 1 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 14 |
| Manufacturing | 2 |
| Consumer & Lifestyle | 2 |
| Enterprise Software | 1 |
| Professional Services | 1 |
| Space & Frontier Tech | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 1 |
| $5M-$10M | 0 |
| $10M-$25M | 8 |
| $25M-$50M | 4 |
| $50M-$100M | 2 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 5 of 5 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Europe | 6 |
| United States | 4 |
| Australia | 2 |
| Singapore | 2 |
| Israel | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| AfriMobility | 1 |
| aMoon | 1 |
| Andera Partners | 1 |
| AT Capital Group | 1 |
| Blast.Club | 1 |
| BNP Paribas Développement | 1 |
| Bpifrance | 1 |
| Brandon Capital | 1 |
| Cancer Focus Fund | 1 |
| Capricorn Venture Partners | 1 |
| Captech Sant | 1 |
| Critical Path Ventures | 1 |
| Dedalus Group | 1 |
| EIC Fund | 1 |
| European Investment Bank | 1 |
| Everlife | 1 |
| FIRA Nord Est | 1 |
| Flerie Invest | 1 |
| FundersClub | 1 |
| LGT Crestone | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 8 | 53% |
| Participating | 7 | 47% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 6 | 75% |
| Co-led | 2 | 25% |